Idenix challenges Gilead's patent rights to Sovaldi® (sofosbuvir)
Clients Idenix Pharmaceuticals LLC
Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent interference against Gilead. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.
Clark v. Sommadossi, Interference 105,871 (Patent Trial and Appeal Board)